Emerson Electric Statistics
Total Valuation
EMR has a market cap or net worth of $76.05 billion. The enterprise value is $87.25 billion.
Market Cap | 76.05B |
Enterprise Value | 87.25B |
Important Dates
The last earnings date was Tuesday, November 5, 2024, before market open.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | Nov 15, 2024 |
Share Statistics
EMR has 572.70 million shares outstanding. The number of shares has decreased by -0.57% in one year.
Current Share Class | 572.70M |
Shares Outstanding | 572.70M |
Shares Change (YoY) | -0.57% |
Shares Change (QoQ) | -0.16% |
Owned by Insiders (%) | 0.34% |
Owned by Institutions (%) | 78.93% |
Float | 570.13M |
Valuation Ratios
The trailing PE ratio is 38.71 and the forward PE ratio is 22.28. EMR's PEG ratio is 2.04.
PE Ratio | 38.71 |
Forward PE | 22.28 |
PS Ratio | 4.37 |
Forward PS | 4.15 |
PB Ratio | 3.53 |
P/TBV Ratio | n/a |
P/FCF Ratio | 26.30 |
P/OCF Ratio | 22.99 |
PEG Ratio | 2.04 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.91, with an EV/FCF ratio of 29.95.
EV / Earnings | 44.33 |
EV / Sales | 4.99 |
EV / EBITDA | 18.91 |
EV / EBIT | 28.92 |
EV / FCF | 29.95 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.30.
Current Ratio | 1.77 |
Quick Ratio | 1.32 |
Debt / Equity | 0.30 |
Debt / EBITDA | 1.72 |
Debt / FCF | 2.87 |
Interest Coverage | 9.34 |
Financial Efficiency
Return on equity (ROE) is 5.93% and return on invested capital (ROIC) is 5.30%.
Return on Equity (ROE) | 5.93% |
Return on Assets (ROA) | 4.34% |
Return on Capital (ROIC) | 5.30% |
Revenue Per Employee | $239,616 |
Profits Per Employee | $26,959 |
Employee Count | 73,000 |
Asset Turnover | 0.40 |
Inventory Turnover | 4.00 |
Taxes
In the past 12 months, EMR has paid $415.00 million in taxes.
Income Tax | 415.00M |
Effective Tax Rate | 20.54% |
Stock Price Statistics
The stock price has increased by +47.42% in the last 52 weeks. The beta is 1.29, so EMR's price volatility has been higher than the market average.
Beta (5Y) | 1.29 |
52-Week Price Change | +47.42% |
50-Day Moving Average | 117.45 |
200-Day Moving Average | 111.25 |
Relative Strength Index (RSI) | 72.32 |
Average Volume (20 Days) | 3,327,026 |
Short Selling Information
The latest short interest is 11.29 million, so 1.97% of the outstanding shares have been sold short.
Short Interest | 11.29M |
Short Previous Month | 8.63M |
Short % of Shares Out | 1.97% |
Short % of Float | 1.98% |
Short Ratio (days to cover) | 3.85 |
Income Statement
In the last 12 months, EMR had revenue of $17.49 billion and earned $1.97 billion in profits. Earnings per share was $3.43.
Revenue | 17.49B |
Gross Profit | 9.12B |
Operating Income | 3.02B |
Pretax Income | 2.17B |
Net Income | 1.97B |
EBITDA | 4.61B |
EBIT | 3.02B |
Earnings Per Share (EPS) | $3.43 |
Balance Sheet
The company has $3.59 billion in cash and $8.36 billion in debt, giving a net cash position of -$4.77 billion or -$8.33 per share.
Cash & Cash Equivalents | 3.59B |
Total Debt | 8.36B |
Net Cash | -4.77B |
Net Cash Per Share | -$8.33 |
Equity (Book Value) | 27.51B |
Book Value Per Share | 37.94 |
Working Capital | 4.45B |
Cash Flow
In the last 12 months, operating cash flow was $3.33 billion and capital expenditures -$419.00 million, giving a free cash flow of $2.91 billion.
Operating Cash Flow | 3.33B |
Capital Expenditures | -419.00M |
Free Cash Flow | 2.91B |
FCF Per Share | $5.09 |
Margins
Gross margin is 52.12%, with operating and profit margins of 17.25% and 11.25%.
Gross Margin | 52.12% |
Operating Margin | 17.25% |
Pretax Margin | 11.55% |
Profit Margin | 11.25% |
EBITDA Margin | 26.38% |
EBIT Margin | 17.25% |
FCF Margin | 6.99% |
Dividends & Yields
This stock pays an annual dividend of $2.10, which amounts to a dividend yield of 1.58%.
Dividend Per Share | $2.10 |
Dividend Yield | 1.58% |
Dividend Growth (YoY) | 0.84% |
Years of Dividend Growth | 67 |
Payout Ratio | 61.30% |
Buyback Yield | 0.57% |
Shareholder Yield | 2.14% |
Earnings Yield | 2.57% |
FCF Yield | 3.80% |
Analyst Forecast
The average price target for EMR is $131.69, which is -0.84% lower than the current price. The consensus rating is "Buy".
Price Target | $131.69 |
Price Target Difference | -0.84% |
Analyst Consensus | Buy |
Analyst Count | 16 |
Revenue Growth Forecast (5Y) | 6.76% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 12, 2006. It was a forward split with a ratio of 2:1.
Last Split Date | Dec 12, 2006 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
EMR has an Altman Z-Score of 4.15 and a Piotroski F-Score of 7.
Altman Z-Score | 4.15 |
Piotroski F-Score | 7 |